Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2010
10/07/2010CA2756864A1 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase)-inhibitory peptide, and use of the peptide
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236136A1 Angiogenesis inhibitor containing amine derivate as active ingredient
10/06/2010EP2235189A1 Methods for inhibiting angiogenesis using egfl8 antagonists
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2234629A1 Stable aqueous cyclosporin compositions
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101854943A Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
10/06/2010CN101854939A 眼科用组合物 Ophthalmic composition
10/06/2010CN101854916A Sustained delivery of compstatin analogs from gels
10/06/2010CN101851300A Process for extracting chondroitin sulfate
10/06/2010CN101851191A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
10/06/2010CN101850118A Preparation method and application in preparation of photodynamic therapy medicines of fat-soluble photosensitizer loaded on inorganic salt carrier
10/06/2010CN101850069A Oral Chinese patent medicament capsule for treating white hair of teenagers
10/06/2010CN101850028A Composition with function of relieving visual fatigue
10/06/2010CN101849905A Voriconazole eye drops and preparation method thereof
10/06/2010CN101601828B Eyesight-recovering traditional Chinese medicine for treating optic neuritis and optic nerve atrophy
10/05/2010US7809417 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807654 Compositions and methods for treatment of mitochondrial diseases
10/05/2010US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
10/05/2010CA2407967C Tubulin binding ligands and corresponding prodrug constructs
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
09/2010
09/30/2010WO2010111449A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010WO2010017626A9 Compositions comprising terpene compounds for treating negative sensory phenomena
09/30/2010US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249134 Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina
09/30/2010US20100249106 Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249082 Modulators of hypoxia inducible factor-1 and related uses
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249062 Ophthalmic composition
09/30/2010US20100249046 Novel mangiferin calcium salts, the method for its preparation and its use
09/30/2010US20100249034 Gfralpha3 and its uses
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins
09/30/2010US20100247694 Composition and method for treament of inflamation and infections of the outer ear canal, nose and paranasal sinuses
09/30/2010US20100247691 Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products
09/30/2010US20100247688 Pirenzepine and derivatives thereof as anti-amyloid agents
09/30/2010US20100247683 Methods of identifying potential components for targeted drug delivery compositions
09/30/2010US20100247659 Phenylphthalimide analogs for treating diabetic macular edema
09/30/2010US20100247631 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
09/30/2010US20100247626 Pegylated compounds for age-related macular degeneration
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010US20100247548 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
09/30/2010US20100247530 Compositions and methods for preventing and treating presbycusis
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247516 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010CA2756181A1 Carrier
09/30/2010CA2756065A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231650A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
09/29/2010EP2231594A2 Potassium ion channel modulators and uses thereof
09/29/2010EP2231162A1 Substituted cyclopentanes having prostaglandin activity
09/29/2010EP2231146A2 Pharmaceutical composition for the treatment and prevention of glaucoma
09/29/2010EP2231137A1 Method of modulating membrane potential of a cell
09/29/2010EP1968594B1 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010CN1923209B Phthiobuzonum eye drops containing sodium hyaluronate and its preparing process
09/29/2010CN1823827B Medicine and food dual purpose nutritive product for preventing and treating xeroma and its manufacturing method
09/29/2010CN1788609B Preparation method of gastrodia tuber essence serial health product
09/29/2010CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent
09/29/2010CN101848715A Two-component eye drops containing pirenoxine
09/29/2010CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/29/2010CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/29/2010CN101843857A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843849A Chinese medicament for treating trachoma and preparation method thereof
09/29/2010CN101843837A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843836A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843834A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843788A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843786A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843785A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843784A Multi-dimensional xanthophyll preparation for powerfully protecting eyesight
09/29/2010CN101843781A Chinese medicinal composition for preventing and treating xerophthalmia
09/29/2010CN101843780A Medicament for treating macular degeneration
09/29/2010CN101843774A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843772A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843770A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843752A Chinese medicament for treating diabetic eyeground pathological changes
09/29/2010CN101843728A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843727A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843725A Chinese medicament for treating diabetic oculopathy
09/29/2010CN101843662A Chinese medicinal composition for preventing and treating asthenopia
09/29/2010CN101843648A Ixeris sonchifolia hance medicinal preparations for treating coronary disease and cerebral thrombosis
09/29/2010CN101843618A Application of berberine and derivatives thereof in preparation of indole amine 2, 3-dioxygenase inhibitor
09/29/2010CN101337931B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these
09/29/2010CN101249218B Chinese medicine prescription for curing glaucoma
09/29/2010CN101185700B Medicine for treating cataract